Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Monolaurin is a monoester formed from glycerol and lauric acid—a medium-chain saturated fatty acid found in coconut oil and human breast milk. It is also known as glycerol monolaurate or glyceryl laurate[3][5]. Monolaurin is used primarily as a dietary supplement to support immune function and maintain healthy intestinal flora. It has demonstrated broad-spectrum antimicrobial activity in vitro against bacteria (including antibiotic-resistant strains), fungi, and lipid-coated viruses such as herpes simplex virus (HSV), influenza virus, HIV, cytomegalovirus (CMV), measles virus, Epstein-Barr virus (EBV), and others[3][4][5]. Its mechanism of action involves disruption of lipid bilayers in microbial membranes or viral envelopes—leading to cell lysis or viral inactivation[5][6]. Monolaurin may also modulate immune responses by stimulating T-cell proliferation via the phosphoinositide signal transduction pathway[6]. While it has Generally Recognized As Safe (GRAS) status for use as a food additive/preservative by the FDA in the United States[3], there are no approved medical indications for its use; clinical evidence supporting its efficacy for treating infections or other conditions remains insufficient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on monolaurin.